HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin-bing Wei Selected Research

hydroxyethylpuerarin

7/2007Hydroxyethylpuerarin attenuates focal cerebral ischemia-reperfusion injury in rats by decreasing TNF-alpha expression and NF-kappaB activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin-bing Wei Research Topics

Disease

2Brain Ischemia (Cerebral Ischemia)
07/2007 - 02/2006
2Reperfusion Injury
07/2007 - 05/2007
2Necrosis
05/2007 - 03/2005
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2007
1Ischemia
07/2007

Drug/Important Bio-Agent (IBA)

1hydroxyethylpuerarinIBA
07/2007
1Proteins (Proteins, Gene)FDA Link
07/2007
1Messenger RNA (mRNA)IBA
07/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007
1NF-kappa B (NF-kB)IBA
07/2007
1acetylpuerarinIBA
05/2007
1CalciumIBA
05/2007
1Dizocilpine Maleate (Dizocilpine)IBA
05/2007
1AngiotensinsIBA
02/2006
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2005